Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neil Aronin

Showing results (81-90 of 103) with videos related to

Pageof 11
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 11, 2016
Exosome-mediated Delivery of Hydrophobically Modified siRNA for Huntingtin mRNA SilencingMarie-Cécile Didiot, Lauren M Hall, Andrew H Coles, et al.
Nature Communications|October 3, 2022
Chemical engineering of therapeutic siRNAs for allele-specific gene silencing in Huntington's disease modelsFaith Conroy, Rachael Miller, Julia F Alterman, et al.
Molecular and Cellular Biology|September 16, 2009
Mutant huntingtin impairs vesicle formation from recycling endosomes by interfering with Rab11 activityXueyi Li, Clive Standley, Ellen Sapp, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 13, 2023
Di-valent siRNA-mediated silencing of MSH3 blocks somatic repeat expansion in mouse models of Huntington's diseaseDaniel O'Reilly, Jillian Belgrad, Chantal Ferguson, et al.
Human Molecular Genetics|August 8, 2002
Increased huntingtin protein length reduces the number of polyglutamine-induced gene expression changes in mouse models of Huntington's diseaseEdmond Y W Chan, Ruth Luthi-Carter, Andrew Strand, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 25, 2015
Recurrent Mutations of Chromatin-Remodeling Genes and Kinase Receptors in Pheochromocytomas and ParagangliomasRodrigo A Toledo, Yuejuan Qin, Zi-Ming Cheng, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 29, 2015
Widespread Central Nervous System Gene Transfer and Silencing After Systemic Delivery of Novel AAV-AS VectorSourav R Choudhury, Anne F Harris, Damien J Cabral, et al.
Nature Genetics|February 16, 2010
Germline mutations in TMEM127 confer susceptibility to pheochromocytomaYuejuan Qin, Li Yao, Elizabeth E King, et al.
Molecular Therapy. Methods & Clinical Development|November 3, 2023
Awake intracerebroventricular delivery and safety assessment of oligonucleotides in a large animal modelHector Ribeiro Benatti, Rachel D Prestigiacomo, Toloo Taghian, et al.
JCI Insight|December 22, 2021
Comparative route of administration studies using therapeutic siRNAs show widespread gene modulation in Dorset sheepChantal M Ferguson, Bruno Mdc Godinho, Julia F Alterman, et al.
Pageof 11

Showing results (81-90 of 103) with videos related to

Sort By:
Pageof 11
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 11, 2016
Exosome-mediated Delivery of Hydrophobically Modified siRNA for Huntingtin mRNA SilencingMarie-Cécile Didiot, Lauren M Hall, Andrew H Coles, et al.
Nature Communications|October 3, 2022
Chemical engineering of therapeutic siRNAs for allele-specific gene silencing in Huntington's disease modelsFaith Conroy, Rachael Miller, Julia F Alterman, et al.
Molecular and Cellular Biology|September 16, 2009
Mutant huntingtin impairs vesicle formation from recycling endosomes by interfering with Rab11 activityXueyi Li, Clive Standley, Ellen Sapp, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 13, 2023
Di-valent siRNA-mediated silencing of MSH3 blocks somatic repeat expansion in mouse models of Huntington's diseaseDaniel O'Reilly, Jillian Belgrad, Chantal Ferguson, et al.
Human Molecular Genetics|August 8, 2002
Increased huntingtin protein length reduces the number of polyglutamine-induced gene expression changes in mouse models of Huntington's diseaseEdmond Y W Chan, Ruth Luthi-Carter, Andrew Strand, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 25, 2015
Recurrent Mutations of Chromatin-Remodeling Genes and Kinase Receptors in Pheochromocytomas and ParagangliomasRodrigo A Toledo, Yuejuan Qin, Zi-Ming Cheng, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 29, 2015
Widespread Central Nervous System Gene Transfer and Silencing After Systemic Delivery of Novel AAV-AS VectorSourav R Choudhury, Anne F Harris, Damien J Cabral, et al.
Nature Genetics|February 16, 2010
Germline mutations in TMEM127 confer susceptibility to pheochromocytomaYuejuan Qin, Li Yao, Elizabeth E King, et al.
Molecular Therapy. Methods & Clinical Development|November 3, 2023
Awake intracerebroventricular delivery and safety assessment of oligonucleotides in a large animal modelHector Ribeiro Benatti, Rachel D Prestigiacomo, Toloo Taghian, et al.
JCI Insight|December 22, 2021
Comparative route of administration studies using therapeutic siRNAs show widespread gene modulation in Dorset sheepChantal M Ferguson, Bruno Mdc Godinho, Julia F Alterman, et al.
Pageof 11